Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,130 | 76,247 | 88,205 | 139,259 | 203,126 |
| Marketable Securities | 765,295 | 817,463 | 688,723 | 643,860 | 816,892 |
| Receivables | 10,577 | 4,109 | 2,810 | 2,206 | 4,378 |
| Inventories | 32,920 | 27,616 | 19,076 | 8,492 | 0 |
| TOTAL | $942,052 | $965,600 | $833,835 | $832,772 | $1,064,231 |
| Non-Current Assets | |||||
| PPE Net | 10,775 | 11,675 | 15,382 | 22,987 | 28,923 |
| Investments And Advances | 310,013 | 638,321 | 29,435 | 313,874 | 266,375 |
| Other Non-Current Assets | 34,385 | 47,603 | 58,466 | 69,085 | 78,207 |
| TOTAL | $355,173 | $697,599 | $103,283 | $405,946 | $373,505 |
| Total Assets | $1,297,225 | $1,663,199 | $937,118 | $1,238,718 | $1,437,736 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,355 | 16,643 | 9,780 | 18,616 | 16,700 |
| Accrued Expenses | 45,459 | 46,861 | 43,167 | 30,350 | 31,967 |
| TOTAL | $82,206 | $81,156 | $67,955 | $62,629 | $59,826 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 21,905 | 41,087 | 58,144 | 75,275 | 85,659 |
| TOTAL | $21,905 | $41,087 | $58,144 | $75,275 | $85,935 |
| Total Liabilities | $104,111 | $122,243 | $126,099 | $137,904 | $145,761 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,592 | 57,296 | 56,195 | 55,285 | 54,638 |
| Common Shares | 75 | 73 | 72 | 71 | 71 |
| Retained earnings | -561,705 | -148,924 | -822,649 | -470,561 | -238,760 |
| Other shareholders' equity | 1,707 | -2,004 | -927 | -13,021 | -1,684 |
| TOTAL | $1,193,114 | $1,540,956 | $811,019 | $1,100,814 | $1,291,975 |
| Total Liabilities And Equity | $1,297,225 | $1,663,199 | $937,118 | $1,238,718 | $1,437,736 |